| Guidelines for diagnosis, treatment, and prevention ofclostridium difficileInfections CM Surawicz, LJ Brandt, DG Binion, AN Ananthakrishnan, SR Curry, ... Official journal of the American College of Gastroenterology| ACG 108 (4 …, 2013 | 2250 | 2013 |
| A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the … EJ Baron, JM Miller, MP Weinstein, SS Richter, PH Gilligan, ... Clinical infectious diseases 57 (4), e22-e121, 2013 | 878 | 2013 |
| A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society … JM Miller, MJ Binnicker, S Campbell, KC Carroll, KC Chapin, PH Gilligan, ... Clinical Infectious Diseases 67 (6), e1-e94, 2018 | 775 | 2018 |
| Emergence of vancomycin resistance in coagulase-negative staphylococci RS Schwalbe, JT Stapleton, PH Gilligan New England Journal of Medicine 316 (15), 927-931, 1987 | 770 | 1987 |
| Microbiology of airway disease in patients with cystic fibrosis PH Gilligan Clinical microbiology reviews 4 (1), 35-51, 1991 | 746 | 1991 |
| Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium JM Bryant, DM Grogono, D Rodriguez-Rincon, I Everall, KP Brown, ... Science 354 (6313), 751-757, 2016 | 551 | 2016 |
| Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis CR Esther Jr, DA Esserman, P Gilligan, A Kerr, PG Noone Journal of Cystic Fibrosis 9 (2), 117-123, 2010 | 434 | 2010 |
| A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis MR Knowles, NL Church, WE Waltner, JR Yankaskas, P Gilligan, M King, ... New England Journal of Medicine 322 (17), 1189-1194, 1990 | 408 | 1990 |
| Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin MA Kelley, DJ Weber, P Gilligan, MS Cohen Clinical Infectious Diseases 31 (4), 1008-1011, 2000 | 300 | 2000 |
| Lung Transplantation for Cystic Fibrosis Patients with Burkholderia cepacia Complex: Survival Linked to Genomovar Type RM Aris, JC Routh, JJ LiPUMA, DG Heath, PH Gilligan American journal of respiratory and critical care medicine 164 (11), 2102-2106, 2001 | 297 | 2001 |
| Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome OC Tablan, TL Chorba, DV Schidlow, JW White, KA Hardy, PH Gilligan, ... The Journal of pediatrics 107 (3), 382-387, 1985 | 284 | 1985 |
| A bacterial cell to cell signal in the lungs of cystic fibrosis patients DN Collier, L Anderson, SL McKnight, TL Noah, M Knowles, R Boucher, ... FEMS microbiology letters 215 (1), 41-46, 2002 | 235 | 2002 |
| Recovery of resistant enterococci during vancomycin prophylaxis AH Kaplan, PH Gilligan, RR Facklam Journal of Clinical Microbiology 26 (6), 1216-1218, 1988 | 208 | 1988 |
| Transmission of Multidrug-Resistant Serotype 23F Streptococcus pneumoniae in Group Day Care: Evidence Suggesting Capsular Transformation of the Resistant … DM Barnes, S Whittier, PH Gilligan, S Soares, A Tomasz, FW Henderson Journal of Infectious Diseases 171 (4), 890-896, 1995 | 202 | 1995 |
| Nasopharyngeal carriage of antibiotic-resistant pneumococci by children in group day care FW Henderson, PH Gilligan, K Wait, DA Goff Journal of Infectious Diseases 157 (2), 256-263, 1988 | 202 | 1988 |
| Nontuberculous mycobacteria in adult patients with cystic fibrosis JM Kilby, PH Gilligan, JR Yankaskas, WE Highsmith Jr, LJ Edwards, ... Chest 102 (1), 70-75, 1992 | 196 | 1992 |
| The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome. RM Aris, PH Gilligan, IP Neuringer, KK Gott, J Rea, JR Yankaskas American journal of respiratory and critical care medicine 155 (5), 1699-1704, 1997 | 193 | 1997 |
| Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms DL Kiska, B Thiede, J Caracciolo, M Jordan, D Johnson, EL Kaplan, ... Journal of Infectious Diseases 176 (4), 992-1000, 1997 | 185 | 1997 |
| Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis DL Kiska, A Kerr, MC Jones, JA Caracciolo, B Eskridge, M Jordan, ... Journal of Clinical Microbiology 34 (4), 886-891, 1996 | 170 | 1996 |
| Cost savings realized by implementation of routine microbiological identification by matrix-assisted laser desorption ionization–time of flight mass spectrometry A Tran, K Alby, A Kerr, M Jones, PH Gilligan Journal of clinical microbiology 53 (8), 2473-2479, 2015 | 164 | 2015 |
Michael KnowlesProfessor of Medicine, Univ of North Carolina在 med.unc.edu 的电子邮件经过验证
